{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:37:47Z","timestamp":1790069867645,"version":"4.0.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11739-026-04278-1","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:44:00Z","timestamp":1770968640000},"page":"843-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nicotine pouches: an aid in smoking cessation, or a new public health hazard?"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6839-4710","authenticated-orcid":false,"given":"Konstantinos","family":"Farsalinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"4278_CR1","unstructured":"World Health Organization. Geneva: World Health Organization; Tobacco: Key facts; 2023 [cited 2024 May 24]. Available from:\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco"},{"key":"4278_CR2","volume-title":"WHO global report on trends in prevalence of tobacco use 2000\u20132025","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021) WHO global report on trends in prevalence of tobacco use 2000\u20132025, 4th edn. World Health Organization, Geneva (9789240039322)","edition":"4"},{"key":"4278_CR3","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014."},{"key":"4278_CR4","unstructured":"European Commission [Internet]. Brussels: European Commission; Public Health: Tobacco; [cited 2024 May 24]. Available from:\u00a0https:\/\/health.ec.europa.eu\/tobacco_en"},{"key":"4278_CR5","volume-title":"WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package","author":"World Health Organization","year":"2008","unstructured":"World Health Organization (2008) WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. World Health Organization, Geneva (9789241596282)"},{"issue":"5","key":"4278_CR6","doi-asserted-by":"publisher","first-page":"CD009329","DOI":"10.1002\/14651858.CD009329.pub2","volume":"2013","author":"K Cahill","year":"2013","unstructured":"Cahill K, Stevens S, Perera R, Lancaster T (2013) Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013(5):CD009329. https:\/\/doi.org\/10.1002\/14651858.CD009329.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"4278_CR7","doi-asserted-by":"publisher","first-page":"CD000146","DOI":"10.1002\/14651858.CD000146.pub3","volume":"11","author":"LF Stead","year":"2012","unstructured":"Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K et al (2012) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 11(11):CD000146. https:\/\/doi.org\/10.1002\/14651858.CD000146.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"10037","key":"4278_CR8","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","volume":"387","author":"RM Anthenelli","year":"2016","unstructured":"Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D et al (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 387(10037):2507\u20132520. https:\/\/doi.org\/10.1016\/S0140-6736(16)30272-0","journal-title":"Lancet"},{"key":"4278_CR9","doi-asserted-by":"publisher","first-page":"b1024","DOI":"10.1136\/bmj.b1024","volume":"338","author":"D Moore","year":"2009","unstructured":"Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P (2009) Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 338:b1024. https:\/\/doi.org\/10.1136\/bmj.b1024","journal-title":"BMJ"},{"issue":"3","key":"4278_CR10","first-page":"425","volume":"10","author":"U Wadgave","year":"2016","unstructured":"Wadgave U, Nagesh L (2016) Nicotine replacement therapy: an overview. Int J Health Sci (Qassim) 10(3):425\u2013435","journal-title":"Int J Health Sci (Qassim)"},{"issue":"6023","key":"4278_CR11","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/bmj.1.6023.1430","volume":"1","author":"MA Russell","year":"1976","unstructured":"Russell MA (1976) Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J 1(6023):1430\u20131433. https:\/\/doi.org\/10.1136\/bmj.1.6023.1430","journal-title":"Br Med J"},{"issue":"1","key":"4278_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1617-9625-12-14","volume":"12","author":"L Ramstr\u00f6m","year":"2014","unstructured":"Ramstr\u00f6m L, Wikmans T (2014) Mortality attributable to tobacco among men in Sweden and other European countries: an analysis of data in a WHO report. Tob Induc Dis 12(1):14. https:\/\/doi.org\/10.1186\/1617-9625-12-14","journal-title":"Tob Induc Dis"},{"issue":"1","key":"4278_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12954-019-0335-1","volume":"16","author":"E Clarke","year":"2019","unstructured":"Clarke E, Thompson K, Weaver S, Thompson J, O\u2019Connell G (2019) Snus: a compelling harm reduction alternative to cigarettes. Harm Reduct J 16(1):62. https:\/\/doi.org\/10.1186\/s12954-019-0335-1","journal-title":"Harm Reduct J"},{"key":"4278_CR14","unstructured":"Google Patents US5939100A. Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof. Pharmacia and Upjohn AB. 1993. Available at: https:\/\/patents.google.com\/patent\/US5939100 (accessed on November 28, 2025)."},{"key":"4278_CR15","unstructured":"Google Patents EP1803444A2. A method for the preparation of a nicotine-containing particulate material with a crystalline cellulose (in particular MCC). Niconovum AB. Available at https:\/\/patents.google.com\/patent\/EP1803444A2\/ (accessed on November 28, 2025)."},{"issue":"8","key":"4278_CR16","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/ntr\/ntaa239","volume":"23","author":"CD Delnevo","year":"2021","unstructured":"Delnevo CD, Hrywna M, Miller Lo EJ, Wackowski OA (2021) Examining market trends in smokeless tobacco sales in the United States: 2011-2019. Nicotine Tob Res 23(8):1420\u20131424. https:\/\/doi.org\/10.1093\/ntr\/ntaa239","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"4278_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/ntr\/ntab198","volume":"24","author":"S Patwardhan","year":"2022","unstructured":"Patwardhan S, Fagerstr\u00f6m K (2022) The new nicotine pouch category: a tobacco harm reduction tool? Nicotine Tob Res 24(4):623\u2013625. https:\/\/doi.org\/10.1093\/ntr\/ntab198","journal-title":"Nicotine Tob Res"},{"issue":"6","key":"4278_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/tobaccocontrol-2021-057056","volume":"32","author":"M Hrywna","year":"2023","unstructured":"Hrywna M, Gumbert TP, Talbot EM, Wackowski OA (2023) Nicotine pouch product awareness, interest and ever use among US adults who smoke, 2021. Tob Control 32(6):782\u2013785. https:\/\/doi.org\/10.1136\/tobaccocontrol-2021-057056","journal-title":"Tob Control"},{"issue":"11","key":"4278_CR19","doi-asserted-by":"publisher","first-page":"e2244393","DOI":"10.1001\/jamanetworkopen.2022.44393","volume":"5","author":"KL Marynak","year":"2022","unstructured":"Marynak KL, Wang X, Borowiecki M, Kim Y, Tynan MA, Emery S et al (2022) Nicotine pouch unit sales in the US, 2019\u20132022. JAMA Netw Open 5(11):e2244393. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44393","journal-title":"JAMA Netw Open"},{"key":"4278_CR20","doi-asserted-by":"publisher","first-page":"175346581774496","DOI":"10.1177\/1753465817744960","volume":"12","author":"K Farsalinos","year":"2018","unstructured":"Farsalinos K (2018) Electronic cigarettes: an aid in smoking cessation, or a new health hazard? Ther Adv Respir Dis 12:1753465817744960. https:\/\/doi.org\/10.1177\/1753465817744960","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"4278_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/ijerph8020613","volume":"8","author":"R Talhout","year":"2011","unstructured":"Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A (2011) Hazardous compounds in tobacco smoke. Int J Environ Res Public Health 8(2):613\u2013628. https:\/\/doi.org\/10.3390\/ijerph8020613","journal-title":"Int J Environ Res Public Health"},{"issue":"9589","key":"4278_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","volume":"370","author":"DM Mannino","year":"2007","unstructured":"Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589):765\u2013773. https:\/\/doi.org\/10.1016\/S0140-6736(07)61380-4","journal-title":"Lancet"},{"issue":"1","key":"4278_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12931-024-03051-2","volume":"26","author":"Z Wang","year":"2025","unstructured":"Wang Z, Lin J, Liang L, Huang F, Yao X, Peng K, Gao Y, Zheng J (2025) Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the global burden of disease study 2021. Respir Res 26(1):2. https:\/\/doi.org\/10.1186\/s12931-024-03051-2","journal-title":"Respir Res"},{"issue":"7137","key":"4278_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/bmj.316.7137.1043","volume":"316","author":"E Prescott","year":"1998","unstructured":"Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J (1998) Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 316(7137):1043\u20131047. https:\/\/doi.org\/10.1136\/bmj.316.7137.1043","journal-title":"BMJ"},{"issue":"9536","key":"4278_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0140-6736(06)69249-0","volume":"368","author":"KK Teo","year":"2006","unstructured":"Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D et al (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368(9536):647\u2013658. https:\/\/doi.org\/10.1016\/S0140-6736(06)69249-0","journal-title":"Lancet"},{"issue":"Suppl 2","key":"4278_CR26","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.lungcan.2004.07.998","volume":"45","author":"AJ Sasco","year":"2004","unstructured":"Sasco AJ, Secretan MB, Straif K (2004) Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45(Suppl 2):S3-9. https:\/\/doi.org\/10.1016\/j.lungcan.2004.07.998","journal-title":"Lung Cancer"},{"issue":"8","key":"4278_CR27","doi-asserted-by":"publisher","first-page":"CD014936","DOI":"10.1002\/14651858.CD014936.pub2","volume":"8","author":"AD Wu","year":"2022","unstructured":"Wu AD, Lindson N, Hartmann-Boyce J, Wahedi A, Hajizadeh A, Theodoulou A, Thomas ET, Lee C, Aveyard P (2022) Smoking cessation for secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 8(8):CD014936. https:\/\/doi.org\/10.1002\/14651858.CD014936.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"4278_CR28","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/ntr\/ntab076","volume":"23","author":"X Wang","year":"2021","unstructured":"Wang X, Qin LQ, Arafa A, Eshak ES, Hu Y, Dong JY (2021) Smoking cessation, weight gain, cardiovascular risk, and all-cause mortality: a meta-analysis. Nicotine Tob Res 23(12):1987\u20131994. https:\/\/doi.org\/10.1093\/ntr\/ntab076","journal-title":"Nicotine Tob Res"},{"key":"4278_CR29","doi-asserted-by":"publisher","first-page":"104323","DOI":"10.1016\/j.critrevonc.2024.104323","volume":"196","author":"H Lai","year":"2024","unstructured":"Lai H, Liu Q, Ye Q, Liang Z, Long Z, Hu Y, Wu Q, Jiang M (2024) Impact of smoking cessation duration on lung cancer mortality: a systematic review and meta-analysis. Crit Rev Oncol Hematol 196:104323. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104323","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4278_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12890-023-02533-1","volume":"23","author":"JH Doo","year":"2023","unstructured":"Doo JH, Kim SM, Park YJ, Kim KH, Oh YH, Kim JS, Park SM (2023) Smoking cessation after diagnosis of COPD is associated with lower all-cause and cause-specific mortality: a nationwide population-based cohort study of South Korean men. BMC Pulm Med 23(1):237. https:\/\/doi.org\/10.1186\/s12890-023-02533-1","journal-title":"BMC Pulm Med"},{"issue":"1","key":"4278_CR31","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1186\/s12889-024-20270-w","volume":"24","author":"S Chen","year":"2024","unstructured":"Chen S, Yang S, Wang S, Li H, Li R, Li H, Shi Y, Yang J, Bao Y, Du S, Zhao M, Wang W, Wang J, Liu M, He Y (2024) Smoking cessation and mortality risk reduction in older adults with long-term smoking history. BMC Public Health 24(1):2821. https:\/\/doi.org\/10.1186\/s12889-024-20270-w","journal-title":"BMC Public Health"},{"issue":"4","key":"4278_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMsa1211128","volume":"368","author":"P Jha","year":"2013","unstructured":"Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368(4):341\u2013350. https:\/\/doi.org\/10.1056\/NEJMsa1211128","journal-title":"N Engl J Med"},{"issue":"12","key":"4278_CR33","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/cac2.12357","volume":"42","author":"H Tu","year":"2022","unstructured":"Tu H, Ye Y, Huang M, Xie K, Chow WH, Zhao H, Wu X (2022) Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types. Cancer Commun 42(12):1421\u20131424. https:\/\/doi.org\/10.1002\/cac2.12357","journal-title":"Cancer Commun"},{"issue":"4","key":"4278_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/pon.3077","volume":"22","author":"CJ Berg","year":"2013","unstructured":"Berg CJ, Thomas AN, Mertens AC, Schauer GL, Pinsker EA, Ahluwalia JS, Khuri FR (2013) Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology 22(4):799\u2013806. https:\/\/doi.org\/10.1002\/pon.3077","journal-title":"Psychooncology"},{"key":"4278_CR35","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.canep.2022.102237","volume":"80","author":"Z Feuer","year":"2022","unstructured":"Feuer Z, Michael J, Morton E, Matulewicz RS, Sheeran P, Shoenbill K, Goldstein A, Sherman S, Bjurlin MA (2022) Systematic review of smoking relapse rates among cancer survivors who quit at the time of cancer diagnosis. Cancer Epidemiol 80:102237. https:\/\/doi.org\/10.1016\/j.canep.2022.102237","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"4278_CR36","first-page":"294","volume":"51","author":"I Vogiatzis","year":"2010","unstructured":"Vogiatzis I, Tsikrika E, Sachpekidis V, Pittas S, Kotsani A (2010) Factors affecting smoking resumption after acute coronary syndromes. Hellenic J Cardiol 51(4):294\u2013300","journal-title":"Hellenic J Cardiol"},{"issue":"22","key":"4278_CR37","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1053\/euhj.1999.1635","volume":"20","author":"TF van Berkel","year":"1999","unstructured":"van Berkel TF, Boersma H, De Baquer D, Deckers JW, Wood D (1999) Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey. Eur Heart J 20(22):1630\u20131637. https:\/\/doi.org\/10.1053\/euhj.1999.1635","journal-title":"Eur Heart J"},{"issue":"1","key":"4278_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12872-020-01641-8","volume":"20","author":"J H\u00f6pner","year":"2020","unstructured":"H\u00f6pner J, Junge U, Schmidt-Pokrzywniak A, Fischer C, Mikolajczyk R (2020) Determinants of persistent smoking after acute myocardial infarction: an observational study. BMC Cardiovasc Disord 20(1):384. https:\/\/doi.org\/10.1186\/s12872-020-01641-8","journal-title":"BMC Cardiovasc Disord"},{"key":"4278_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drugalcdep.2017.01.001","volume":"174","author":"LT Kozlowski","year":"2017","unstructured":"Kozlowski LT, Warner KE (2017) Adolescents and e-cigarettes: objects of concern may appear larger than they are. Drug Alcohol Depend 174:209\u2013214. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.001","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"4278_CR40","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1080\/01480545.2021.1925691","volume":"45","author":"D Azzopardi","year":"2022","unstructured":"Azzopardi D, Liu C, Murphy J (2022) Chemical characterization of tobacco-free \u201cmodern\u201d oral nicotine pouches and their position on the toxicant and risk continuums. Drug Chem Toxicol 45(5):2246\u20132254. https:\/\/doi.org\/10.1080\/01480545.2021.1925691","journal-title":"Drug Chem Toxicol"},{"issue":"1","key":"4278_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13065-023-00918-1","volume":"17","author":"S Back","year":"2023","unstructured":"Back S, Masser AE, Rutqvist LE, Lindholm J (2023) Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs). BMC Chem 17(1):9. https:\/\/doi.org\/10.1186\/s13065-023-00918-1","journal-title":"BMC Chem"},{"issue":"9","key":"4278_CR42","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/ntr\/ntab030","volume":"23","author":"S Stanfill","year":"2021","unstructured":"Stanfill S, Tran H, Tyx R, Fernandez C, Zhu W, Marynak K, King B, Valent\u00edn-Blasini L, Blount BC, Watson C (2021) Characterization of total and unprotonated (free) nicotine content of nicotine pouch products. Nicotine Tob Res 23(9):1590\u20131596. https:\/\/doi.org\/10.1093\/ntr\/ntab030","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"4278_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/tc-2022-057280","volume":"33","author":"N Mallock","year":"2024","unstructured":"Mallock N, Schulz T, Malke S, Dreiack N, Laux P, Luch A (2024) Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches. Tob Control 33(2):193\u2013199. https:\/\/doi.org\/10.1136\/tc-2022-057280","journal-title":"Tob Control"},{"issue":"2","key":"4278_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1021\/acs.chemrestox.6b00268","volume":"30","author":"SH Edwards","year":"2017","unstructured":"Edwards SH, Rossiter LM, Taylor KM, Holman MR, Zhang L, Ding YS, Watson CH (2017) Tobacco-specific nitrosamines in the tobacco and mainstream smoke of U.S. commercial cigarettes. Chem Res Toxicol 30(2):540\u2013551. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00268","journal-title":"Chem Res Toxicol"},{"issue":"12","key":"4278_CR45","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1080\/14622200802443544","volume":"10","author":"I Stepanov","year":"2008","unstructured":"Stepanov I, Jensen J, Hatsukami D, Hecht SS (2008) New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 10(12):1773\u20131782. https:\/\/doi.org\/10.1080\/14622200802443544","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"4278_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-7517-8-11","volume":"8","author":"LE Rutqvist","year":"2011","unstructured":"Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I (2011) Swedish snus and the GothiaTek\u00ae standard. Harm Reduct J 8(1):11. https:\/\/doi.org\/10.1186\/1477-7517-8-11","journal-title":"Harm Reduct J"},{"issue":"1","key":"4278_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1057\/jphp.2010.41","volume":"32","author":"Z Cahn","year":"2011","unstructured":"Cahn Z, Siegel M (2011) Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 32(1):16\u201331. https:\/\/doi.org\/10.1057\/jphp.2010.41","journal-title":"J Public Health Policy"},{"issue":"2","key":"4278_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/2042098614524430","volume":"5","author":"KE Farsalinos","year":"2014","unstructured":"Farsalinos KE, Polosa R (2014) Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 5(2):67\u201386. https:\/\/doi.org\/10.1177\/2042098614524430","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"4278_CR49","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.3390\/ijerph120403439","volume":"12","author":"KE Farsalinos","year":"2015","unstructured":"Farsalinos KE, Gillman IG, Melvin MS, Paolantonio AR, Gardow WJ, Humphries KE, Brown SE, Poulas K, Voudris V (2015) Nicotine levels and presence of selected tobacco-derived toxins in tobacco flavoured electronic cigarette refill liquids. Int J Environ Res Public Health 12(4):3439\u20133452. https:\/\/doi.org\/10.3390\/ijerph120403439","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"4278_CR50","doi-asserted-by":"publisher","first-page":"9046","DOI":"10.3390\/ijerph120809046","volume":"12","author":"KE Farsalinos","year":"2015","unstructured":"Farsalinos KE, Gillman G, Poulas K, Voudris V (2015) Tobacco-specific nitrosamines in electronic cigarettes: comparison between liquid and aerosol levels. Int J Environ Res Public Health 12(8):9046\u20139053. https:\/\/doi.org\/10.3390\/ijerph120809046","journal-title":"Int J Environ Res Public Health"},{"key":"4278_CR51","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.toxrep.2022.06.008","volume":"9","author":"J Miller-Holt","year":"2022","unstructured":"Miller-Holt J, Baskerville-Abraham I, Sakimura M, Fukushima T, Puglisi A, Gafner J (2022) In vitro evaluation of mutagenic, cytotoxic, genotoxic and oral irritation potential of nicotine pouch products. Toxicol Rep 9:1316\u20131324. https:\/\/doi.org\/10.1016\/j.toxrep.2022.06.008","journal-title":"Toxicol Rep"},{"key":"4278_CR52","doi-asserted-by":"publisher","first-page":"1452274","DOI":"10.3389\/ftox.2024.1452274","volume":"6","author":"BM Keyser","year":"2024","unstructured":"Keyser BM, Leverette R, McRae R, Wertman J, Shutsky T, Szeliga K, Makena P, Jordan KG (2024) In vitro toxicological evaluation of pouched portioned oral nicotine products. Front Toxicol 6:1452274. https:\/\/doi.org\/10.3389\/ftox.2024.1452274","journal-title":"Front Toxicol"},{"key":"4278_CR53","doi-asserted-by":"publisher","first-page":"111713","DOI":"10.1016\/j.fct.2020.111713","volume":"145","author":"E Bishop","year":"2020","unstructured":"Bishop E, East N, Bozhilova S, Santopietro S, Smart D, Taylor M, Meredith S, Baxter A, Breheny D, Thorne D, Gaca M (2020) An approach for the extract generation and toxicological assessment of tobacco-free \u201cmodern\u201d oral nicotine pouches. Food Chem Toxicol 145:111713. https:\/\/doi.org\/10.1016\/j.fct.2020.111713","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4278_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/aivt.2021.0020","volume":"8","author":"F Yu","year":"2022","unstructured":"Yu F, Rudd K, Pour SJ, Trelles Sticken E, Dethloff O, Wieczorek R, Nahde T, Simms L, Chapman F, Czekala L, Stevenson M, O\u2019Connell G (2022) Preclinical assessment of tobacco-free nicotine pouches demonstrates reduced in vitro toxicity compared with tobacco snus and combustible cigarette smoke. Appl In Vitro Toxicol 8(1):24\u201335. https:\/\/doi.org\/10.1089\/aivt.2021.0020","journal-title":"Appl In Vitro Toxicol"},{"key":"4278_CR55","doi-asserted-by":"publisher","first-page":"503738","DOI":"10.1016\/j.mrgentox.2024.503738","volume":"895","author":"F Yu","year":"2024","unstructured":"Yu F, Bishop E, Miazzi F, Evans R, Smart D, Breheny D, Thorne D (2024) Multi-endpoint in vitro toxicological assessment of snus and tobacco-free nicotine pouch extracts. Mutat Res-Genet Toxicol Environ Mutagen 895:503738. https:\/\/doi.org\/10.1016\/j.mrgentox.2024.503738","journal-title":"Mutat Res-Genet Toxicol Environ Mutagen"},{"issue":"9","key":"4278_CR56","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00204-023-03554-9","volume":"97","author":"S Rinaldi","year":"2023","unstructured":"Rinaldi S, Pieper E, Schulz T, Zimmermann R, Luch A, Laux P, Mallock-Ohnesorg N (2023) Oral nicotine pouches with an aftertaste? Part 2: in vitro toxicity in human gingival fibroblasts. Arch Toxicol 97(9):2343\u20132356. https:\/\/doi.org\/10.1007\/s00204-023-03554-9","journal-title":"Arch Toxicol"},{"key":"4278_CR57","unstructured":"Institute of Medicine (US) Committee to Assess the Science Base for Tobacco Harm Reduction; Stratton K, Shetty P, Wallace R, et al., editors. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington (DC): National Academies Press (US); 2001. 11, Exposure and Biomarker Assessment in Humans. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK222378\/"},{"issue":"1","key":"4278_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/1354750X.2022.2148747","volume":"28","author":"D Azzopardi","year":"2023","unstructured":"Azzopardi D, Haswell LE, Frosina J, McEwan M, Gale N, Thissen J, Meichanetzidis F, Hardie G (2023) Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers. Biomarkers 28(1):118\u2013129. https:\/\/doi.org\/10.1080\/1354750X.2022.2148747","journal-title":"Biomarkers"},{"key":"4278_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaf185","author":"HD Dai","year":"2025","unstructured":"Dai HD, Young B (2025) Biomarkers of exposure to tobacco-related toxicants among adult nicotine pouch users. Nicotine Tob Res. https:\/\/doi.org\/10.1093\/ntr\/ntaf185","journal-title":"Nicotine Tob Res"},{"issue":"10","key":"4278_CR60","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/jcph.2293","volume":"63","author":"J Rensch","year":"2023","unstructured":"Rensch J, Edmiston J, Wang J, Jin X, Sarkar M (2023) A randomized, controlled study to assess changes in biomarkers of exposures among adults who smoke that switch to oral nicotine pouch products relative to continuing smoking or stopping all tobacco use. J Clin Pharmacol 63(10):1108\u20131118. https:\/\/doi.org\/10.1002\/jcph.2293","journal-title":"J Clin Pharmacol"},{"key":"4278_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3290\/j.ohpd.c_1925","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, Edmiston JS, Wang J, Milleman KR, Milleman JL, Yoder AL, Gogova M, Sarkar MA (2025) Oral health effects among adults switching from cigarettes to on!\u00ae nicotine pouches compared to those who continue smoking. Oral Health Prev Dent 23:189\u2013201. https:\/\/doi.org\/10.3290\/j.ohpd.c_1925","journal-title":"Oral Health Prev Dent"},{"issue":"4","key":"4278_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0714.1976.tb01769.x","volume":"5","author":"T Ax\u00e9ll","year":"1976","unstructured":"Ax\u00e9ll T, M\u00f6rnstad H, Sundstr\u00f6m B (1976) The relation of the clinical picture to the histopathology of snuff dipper\"s lesions in a Swedish population. J Oral Pathol Oral Med 5(4):229\u2013236","journal-title":"J Oral Pathol Oral Med"},{"issue":"4","key":"4278_CR63","doi-asserted-by":"publisher","first-page":"e12885","DOI":"10.1111\/eos.12885","volume":"130","author":"S Alizadehgharib","year":"2022","unstructured":"Alizadehgharib S, Lehrkinder A, Alshabeeb A, \u00d6stberg AK, Lingstr\u00f6m P (2022) The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus). Eur J Oral Sci 130(4):e12885. https:\/\/doi.org\/10.1111\/eos.12885","journal-title":"Eur J Oral Sci"},{"issue":"27","key":"4278_CR64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2340\/aos.v84.43805","volume":"84","author":"GRM La Rosa","year":"2025","unstructured":"La Rosa GRM, Fagerstr\u00f6m K, Pacino SA, Kowalski J, G\u00f3rska R, Gospodaru S, Bordeniuc G, Fala V, Amaliya A, Chapple I, Polosa R (2025) Self-reported oral health outcomes after switching to a novel nicotine pouch technology: a pilot study. Acta Odontol Scand 84(27):292\u2013298. https:\/\/doi.org\/10.2340\/aos.v84.43805","journal-title":"Acta Odontol Scand"},{"key":"4278_CR65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13000-024-01549-3","volume":"19","author":"S Miluna-Meldere","year":"2024","unstructured":"Miluna-Meldere S, Vanka SA, Skadins I, Kroica J, Sperga M, Rostoka D (2024) Oral mucosal changes caused by nicotine pouches: case series. Diagn Pathol 19:127. https:\/\/doi.org\/10.1186\/s13000-024-01549-3. (Erratum in: Diagn Pathol. 2025 Jan 28;20(1):12. doi: 10.1186\/s13000-025-01606-5.)","journal-title":"Diagn Pathol"},{"issue":"24","key":"4278_CR66","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/microorganisms12081514","volume":"12","author":"S Miluna-Meldere","year":"2024","unstructured":"Miluna-Meldere S, Rostoka D, Broks R, Viksne K, Ciematnieks R, Skadins I, Kroica J (2024) The effects of nicotine pouches and e-cigarettes on oral microbes: a pilot study. Microorganisms 12(24):1514. https:\/\/doi.org\/10.3390\/microorganisms12081514","journal-title":"Microorganisms"},{"issue":"22","key":"4278_CR67","doi-asserted-by":"publisher","first-page":"1392027","DOI":"10.3389\/fphar.2024.1392027","volume":"15","author":"N Mallock-Ohnesorg","year":"2024","unstructured":"Mallock-Ohnesorg N, Rabenstein A, Stoll Y, Gertzen M, Rieder B, Malke S, Burgmann N, Laux P, Pieper E, Schulz T, Franzen K, Luch A, R\u00fcther T (2024) Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches. Front Pharmacol 15(22):1392027","journal-title":"Front Pharmacol"},{"key":"4278_CR68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ntr\/ntad179","volume":"26","author":"AN Dowd","year":"2024","unstructured":"Dowd AN, Thrul J, Czaplicki L, Kennedy RD, Moran MB, Spindle TR (2024) A cross-sectional survey on oral nicotine pouches: characterizing use-motives, topography, dependence levels, and adverse events. Nicotine Tob Res 26:245\u2013249. https:\/\/doi.org\/10.1093\/ntr\/ntad179","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"4278_CR69","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2105\/ajph.84.3.399","volume":"84","author":"G Bolinder","year":"1994","unstructured":"Bolinder G, Alfredsson L, Englund A, de Faire U (1994) Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 84(3):399\u2013404. https:\/\/doi.org\/10.2105\/ajph.84.3.399","journal-title":"Am J Public Health"},{"issue":"7","key":"4278_CR70","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1470-2045(08)70173-6","volume":"9","author":"P Boffetta","year":"2008","unstructured":"Boffetta P, Hecht S, Gray N, Gupta P, Straif K (2008) Smokeless tobacco and cancer. Lancet Oncol 9(7):667\u2013675. https:\/\/doi.org\/10.1016\/S1470-2045(08)70173-6","journal-title":"Lancet Oncol"},{"issue":"6","key":"4278_CR71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1477-7517-10-36","volume":"10","author":"PN Lee","year":"2013","unstructured":"Lee PN (2013) Epidemiological evidence relating snus to health--an updated review based on recent publications. Harm Reduct J 10(6):36. https:\/\/doi.org\/10.1186\/1477-7517-10-36","journal-title":"Harm Reduct J"},{"issue":"3","key":"4278_CR72","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1186\/s12889-025-23280-4","volume":"25","author":"HG Cheng","year":"2025","unstructured":"Cheng HG, Noggle B, Flora JW (2025) Comparative disease risks associated with cigarette smoking and use of moist smokeless tobacco and snus: an umbrella review of epidemiological evidence from the United States and Western Europe. BMC Public Health 25(3):3765. https:\/\/doi.org\/10.1186\/s12889-025-23280-4","journal-title":"BMC Public Health"},{"issue":"15","key":"4278_CR73","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/s0735-1097(99)00409-x","volume":"34","author":"F Huhtasaari","year":"1999","unstructured":"Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K (1999) Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 34(15):1784\u20131790. https:\/\/doi.org\/10.1016\/s0735-1097(99)00409-x","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4278_CR74","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10654-012-9704-8","volume":"27","author":"J Hansson","year":"2012","unstructured":"Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Hallqvist J, Hedblad B, Jansson JH, Nilsson P, Pedersen N, Trolle Lagerros Y, Ostergren PO, Magnusson C (2012) Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol 27(10):771\u2013779. https:\/\/doi.org\/10.1007\/s10654-012-9704-8","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"4278_CR75","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF02247429","volume":"108","author":"H Holm","year":"1992","unstructured":"Holm H, Jarvis MJ, Russell MA, Feyerabend C (1992) Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology 108(4):507\u2013511. https:\/\/doi.org\/10.1007\/BF02247429","journal-title":"Psychopharmacology"},{"issue":"4","key":"4278_CR76","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/ije\/dym039","volume":"36","author":"PN Lee","year":"2007","unstructured":"Lee PN (2007) Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol 36(4):789\u2013804. https:\/\/doi.org\/10.1093\/ije\/dym039","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4278_CR77","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.113.007252","volume":"130","author":"G Arefalk","year":"2014","unstructured":"Arefalk G, Hambraeus K, Lind L, Micha\u00eblsson K, Lindahl B, Sundstr\u00f6m J (2014) Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation 130(4):325\u2013332. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.007252","journal-title":"Circulation"},{"issue":"1","key":"4278_CR78","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/joim.12219","volume":"276","author":"M Eriksson","year":"2014","unstructured":"Eriksson M, Hallqvist J, Hedblad B, Jansson JH, Pedersen NL, Trolle Lagerros Y, Ostergren PO, Magnusson C (2014) Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med 276(1):87\u201395. https:\/\/doi.org\/10.1111\/joim.12219","journal-title":"J Intern Med"},{"issue":"2","key":"4278_CR79","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.yrtph.2010.12.002","volume":"59","author":"PN Lee","year":"2011","unstructured":"Lee PN (2011) Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 59(2):197\u2013214. https:\/\/doi.org\/10.1016\/j.yrtph.2010.12.002","journal-title":"Regul Toxicol Pharmacol"},{"issue":"8","key":"4278_CR80","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1177\/1403494820919572","volume":"49","author":"M Araghi","year":"2021","unstructured":"Araghi M, Galanti MR, Lundberg M, Liu Z, Ye W, Lager A, Engstr\u00f6m G, Alfredsson L, Knutsson A, Norberg M, Wennberg P, Lagerros YT, Bellocco R, Pedersen NL, \u00d6stergren PO, Magnusson C (2021) No association between moist oral snuff (snus) use and oral cancer: pooled analysis of nine prospective observational studies. Scand J Public Health 49(8):833\u2013840. https:\/\/doi.org\/10.1177\/1403494820919572","journal-title":"Scand J Public Health"},{"issue":"9","key":"4278_CR81","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ntr\/nty074","volume":"21","author":"S Asthana","year":"2019","unstructured":"Asthana S, Labani S, Kailash U, Sinha DN, Mehrotra R (2019) Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine Tob Res 21(9):1162\u20131171. https:\/\/doi.org\/10.1093\/ntr\/nty074","journal-title":"Nicotine Tob Res"},{"issue":"9578","key":"4278_CR82","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(07)60678-3","volume":"369","author":"J Luo","year":"2007","unstructured":"Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, Nyr\u00e9n O (2007) Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 369(9578):2015\u20132020. https:\/\/doi.org\/10.1016\/S0140-6736(07)60678-3","journal-title":"Lancet"},{"issue":"4","key":"4278_CR83","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ijc.30773","volume":"141","author":"M Araghi","year":"2017","unstructured":"Araghi M, Rosaria Galanti M, Lundberg M, Lager A, Engstr\u00f6m G, Alfredsson L, Knutsson A, Norberg M, Sund M, Wennberg P, Trolle Lagerros Y, Bellocco R, Pedersen NL, \u00d6stergren PO, Magnusson C (2017) Use of moist oral snuff (snus) and pancreatic cancer: pooled analysis of nine prospective observational studies. Int J Cancer 141(4):687\u2013693. https:\/\/doi.org\/10.1002\/ijc.30773","journal-title":"Int J Cancer"},{"issue":"8","key":"4278_CR84","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/1403494817714191","volume":"45","author":"M Araghi","year":"2017","unstructured":"Araghi M, Galanti MR, Lundberg M, Liu Z, Ye W, Lager A, Engstr\u00f6m G, Manjer J, Alfredsson L, Knutsson A, Norberg M, Palmqvist R, Gylling B, Wennberg P, Lagerros YT, Bellocco R, Pedersen NL, \u00d6stergren PO, Magnusson C (2017) Smokeless tobacco (snus) use and colorectal cancer incidence and survival: results from nine pooled cohorts. Scand J Public Health 45(8):741\u2013748. https:\/\/doi.org\/10.1177\/1403494817714191","journal-title":"Scand J Public Health"},{"issue":"12","key":"4278_CR85","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/ijc.34643","volume":"153","author":"H Valen","year":"2023","unstructured":"Valen H, Becher R, Vist GE, Holme JA, Mdala I, Elvsaas I\u00d8, Alexander J, Underland V, Brinchmann BC, Grimsrud TK (2023) A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco. Int J Cancer 153(12):1942\u20131953. https:\/\/doi.org\/10.1002\/ijc.34643","journal-title":"Int J Cancer"},{"issue":"1","key":"4278_CR86","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.amepre.2023.01.016","volume":"65","author":"OE Titova","year":"2023","unstructured":"Titova OE, Baron JA, Fall T, Micha\u00eblsson K, Larsson SC (2023) Swedish snuff (Snus), cigarette smoking, and risk of type 2 diabetes. Am J Prev Med 65(1):60\u201366. https:\/\/doi.org\/10.1016\/j.amepre.2023.01.016","journal-title":"Am J Prev Med"},{"issue":"6","key":"4278_CR87","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.eprac.2022.03.004","volume":"28","author":"AH Kim","year":"2022","unstructured":"Kim AH, Seo IH, Lee HS, Lee YJ (2022) Long-term adverse effects of cigarette smoking on the incidence risk of metabolic syndrome with a dose-response relationship: longitudinal findings of the Korean Genome and Epidemiology Study over 12 years. Endocr Pract 28(6):603\u2013609. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.004","journal-title":"Endocr Pract"},{"issue":"4","key":"4278_CR88","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/dme.13179","volume":"34","author":"B Rasouli","year":"2017","unstructured":"Rasouli B, Andersson T, Carlsson PO, Grill V, Groop L, Martinell M, Midthjell K, Storm P, Tuomi T, Carlsson S (2017) Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA). Diabet Med 34(4):514\u2013521. https:\/\/doi.org\/10.1111\/dme.13179","journal-title":"Diabet Med"},{"issue":"2","key":"4278_CR89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2796.2004.01344.x","volume":"256","author":"M Eliasson","year":"2004","unstructured":"Eliasson M, Asplund K, Nasic S, Rodu B (2004) Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med 256(2):101\u2013110. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01344.x","journal-title":"J Intern Med"},{"issue":"8","key":"4278_CR90","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1177\/1403494812459814","volume":"40","author":"CG \u00d6stenson","year":"2012","unstructured":"\u00d6stenson CG, Hilding A, Grill V, Efendic S (2012) High consumption of smokeless tobacco (\u201csnus\u201d) predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men. Scand J Public Health 40(8):730\u2013737. https:\/\/doi.org\/10.1177\/1403494812459814","journal-title":"Scand J Public Health"},{"issue":"6","key":"4278_CR91","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/ntr\/ntae267","volume":"27","author":"A Zettergren","year":"2025","unstructured":"Zettergren A, Andersson N, Pershagen G, Lindh C, Georgelis A, Kull I, Mel\u00e9n E, Ekstr\u00f6m S, Ljungman P, Bergstr\u00f6m A (2025) Snus and cardiometabolic health markers among Swedish young adults. Nicotine Tob Res 27(6):1098\u20131108. https:\/\/doi.org\/10.1093\/ntr\/ntae267","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"4278_CR92","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00365513.2023.2209915","volume":"83","author":"ML Byhamre","year":"2023","unstructured":"Byhamre ML, Eliasson M, S\u00f6derberg S, Wennberg P, Oskarsson V (2023) Association between snus use and lipid status in Swedish men. Scand J Clin Lab Invest 83(4):241\u2013250. https:\/\/doi.org\/10.1080\/00365513.2023.2209915","journal-title":"Scand J Clin Lab Invest"},{"key":"4278_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/add.70193","author":"J Heshmati","year":"2025","unstructured":"Heshmati J, Shahen S, Bates EL, Visintini S, Quirouette E, Mullen KA, Mir H (2025) Nicotine pouches and clinical outcomes related to smoking cessation: a systematic review of randomized trials. Addiction. https:\/\/doi.org\/10.1111\/add.70193","journal-title":"Addiction"},{"issue":"2","key":"4278_CR94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ntr\/ntp189","volume":"12","author":"B Caldwell","year":"2010","unstructured":"Caldwell B, Burgess C, Crane J (2010) Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers. Nicotine Tob Res 12(2):179\u2013183. https:\/\/doi.org\/10.1093\/ntr\/ntp189","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"4278_CR95","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ntr\/ntae047","volume":"26","author":"JC Avila","year":"2024","unstructured":"Avila JC, Maglalang DD, Nollen NL, Lee SC, Suh R, Malone M, Binjrajka U, Ahluwalia JS (2024) Using pod based e-cigarettes and nicotine pouches to reduce harm for adults with low socioeconomic status who smoke: a pilot randomized controlled trial. Nicotine Tob Res 26(9):1150\u20131158. https:\/\/doi.org\/10.1093\/ntr\/ntae047","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"4278_CR96","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s00213-022-06178-6","volume":"239","author":"F Chapman","year":"2022","unstructured":"Chapman F, McDermott S, Rudd K, Taverner V, Stevenson M, Chaudhary N, Reichmann K, Thompson J, Nahde T, O\u2019Connell G (2022) A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes. Psychopharmacology 239(9):2931\u20132943. https:\/\/doi.org\/10.1007\/s00213-022-06178-6","journal-title":"Psychopharmacology"},{"issue":"9","key":"4278_CR97","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s00213-022-06172-y","volume":"239","author":"J Liu","year":"2022","unstructured":"Liu J, Rensch J, Wang J, Jin X, Vansickel A, Edmiston J, Sarkar M (2022) Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users. Psychopharmacology 239(9):2863\u20132873. https:\/\/doi.org\/10.1007\/s00213-022-06172-y","journal-title":"Psychopharmacology"},{"issue":"2","key":"4278_CR98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s13318-021-00742-9","volume":"47","author":"M McEwan","year":"2022","unstructured":"McEwan M, Azzopardi D, Gale N, Camacho OM, Hardie G, Fearon IM, Murphy J (2022) A randomised study to investigate the nicotine pharmacokinetics of oral nicotine pouches and a combustible cigarette. Eur J Drug Metab Pharmacokinet 47(2):211\u2013221. https:\/\/doi.org\/10.1007\/s13318-021-00742-9","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"11","key":"4278_CR99","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1007\/s00213-021-05948-y","volume":"238","author":"J Rensch","year":"2021","unstructured":"Rensch J, Liu J, Wang J, Vansickel A, Edmiston J, Sarkar M (2021) Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!\u00ae nicotine pouches compared to combustible cigarettes. Psychopharmacology 238(11):3325\u20133334. https:\/\/doi.org\/10.1007\/s00213-021-05948-y","journal-title":"Psychopharmacology"},{"issue":"6","key":"4278_CR100","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ntr\/ntp054","volume":"11","author":"S Thornley","year":"2009","unstructured":"Thornley S, McRobbie H, Lin RB, Bullen C, Hajek P, Laugesen M, Senior H, Whittaker R (2009) A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction. Nicotine Tob Res 11(6):715\u2013721. https:\/\/doi.org\/10.1093\/ntr\/ntp054","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"4278_CR101","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/add.12429","volume":"109","author":"D Kotz","year":"2014","unstructured":"Kotz D, Brown J, West R (2014) \u201cReal-world\u201d effectiveness of smoking cessation treatments: a population study. Addiction 109(3):491\u2013499. https:\/\/doi.org\/10.1111\/add.12429","journal-title":"Addiction"},{"key":"4278_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2022.107442","volume":"135","author":"SE Jackson","year":"2022","unstructured":"Jackson SE, Kock L, Kotz D, Brown J (2022) Real-world effectiveness of smoking cessation aids: a population survey in England with 12-month follow-up, 2015-2020. Addict Behav 135:107442. https:\/\/doi.org\/10.1016\/j.addbeh.2022.107442","journal-title":"Addict Behav"},{"issue":"10","key":"4278_CR103","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/ntr\/ntaa068","volume":"22","author":"E Lunell","year":"2020","unstructured":"Lunell E, Fagerstr\u00f6m K, Hughes J, Pendrill R (2020) Pharmacokinetic comparison of a novel non-tobacco-based nicotine pouch (ZYN) with conventional, tobacco-based Swedish snus and American moist snuff. Nicotine Tob Res 22(10):1757\u20131763. https:\/\/doi.org\/10.1093\/ntr\/ntaa068","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"4278_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10544-x","volume":"12","author":"D Azzopardi","year":"2022","unstructured":"Azzopardi D, Ebajemito J, McEwan M, Camacho OM, Thissen J, Hardie G, Voisine R, Mullard G, Cohen Z, Murphy J (2022) A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products. Sci Rep 12(1):6949. https:\/\/doi.org\/10.1038\/s41598-022-10544-x","journal-title":"Sci Rep"},{"issue":"11","key":"4278_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13111110","volume":"13","author":"L Ramstr\u00f6m","year":"2016","unstructured":"Ramstr\u00f6m L, Borland R, Wikmans T (2016) Patterns of smoking and snus use in Sweden: implications for public health. Int J Environ Res Public Health 13(11):1110. https:\/\/doi.org\/10.3390\/ijerph13111110","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"4278_CR106","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/tc.2005.014969","volume":"15","author":"LM Ramstr\u00f6m","year":"2006","unstructured":"Ramstr\u00f6m LM, Foulds J (2006) Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 15(3):210\u2013214. https:\/\/doi.org\/10.1136\/tc.2005.014969","journal-title":"Tob Control"},{"issue":"1","key":"4278_CR107","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1360-0443.2010.03122.x","volume":"106","author":"KE Lund","year":"2011","unstructured":"Lund KE, Scheffels J, McNeill A (2011) The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies. Addiction 106(1):162\u2013167. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03122.x","journal-title":"Addiction"},{"key":"4278_CR108","unstructured":"Grand View Research, Inc. Nicotine pouches market size, share & trends analysis report by product type (tobacco-derived nicotine, synthetic nicotine), by distribution channel (offline, online), by flavor, by strength, by region, and segment forecasts, 2025\u20132030. Grand View Research; 2025. Available from: https:\/\/www.grandviewresearch.com\/industry-analysis\/nicotine-pouchesmarket-report."},{"key":"4278_CR109","unstructured":"CDC Foundation. Monitoring Sales: Nicotine Pouch Trends. Tobacco Monitoring. 2025 Jan 10. Available from: https:\/\/tobaccomonitoring.org\/wp-content\/uploads\/2025\/01\/Nicotine-Pouch-Brief_1.10.2025.pdf"},{"key":"4278_CR110","unstructured":"CDC Foundation. Monitoring Sales: Nicotine Pouch Trends. Tobacco Monitoring. 2025 Apr 20. Available from: https:\/\/tobaccomonitoring.org\/wp-content\/uploads\/2025\/07\/Nicotine-Pouch-Brief-4.20.2025.pdf"},{"key":"4278_CR111","doi-asserted-by":"publisher","DOI":"10.1136\/tc-2024-059222","author":"Y He","year":"2025","unstructured":"He Y, Zhang Z, Keller-Hamilton B, Mays D, Wagener TL, Berman ML, Shang C (2025) Trends of oral nicotine pouch prices and sales by product characteristics in the USA, 2021\u20132024. Tob Control. https:\/\/doi.org\/10.1136\/tc-2024-059222","journal-title":"Tob Control"},{"issue":"9","key":"4278_CR112","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jama.2024.10686","volume":"332","author":"HD Dai","year":"2024","unstructured":"Dai HD, Leventhal AM (2024) Prevalence of nicotine pouch use among US adults. JAMA 332(9):755\u2013757. https:\/\/doi.org\/10.1001\/jama.2024.10686","journal-title":"JAMA"},{"issue":"9","key":"4278_CR113","doi-asserted-by":"publisher","first-page":"e2531155","DOI":"10.1001\/jamanetworkopen.2025.31155","volume":"8","author":"CD Delnevo","year":"2025","unstructured":"Delnevo CD, Tomaino M, Hrywna M, Bover Manderski MT (2025) Patterns of nicotine pouch use among adults in the US, 2022-2023. JAMA Netw Open 8(9):e2531155. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.31155","journal-title":"JAMA Netw Open"},{"issue":"12","key":"4278_CR114","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jama.2025.0543","volume":"333","author":"S Anderer","year":"2025","unstructured":"Anderer S (2025) FDA authorizes marketing of ZYN nicotine pouch products. JAMA 333(12):1023. https:\/\/doi.org\/10.1001\/jama.2025.0543","journal-title":"JAMA"},{"key":"4278_CR115","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/192522","author":"M Jankowski","year":"2024","unstructured":"Jankowski M, Rees VW (2024) Awareness and use of nicotine pouches in a nationwide sample of adults in Poland. Tob Induc Dis. https:\/\/doi.org\/10.18332\/tid\/192522","journal-title":"Tob Induc Dis"},{"issue":"9","key":"4278_CR116","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/ntr\/ntac099","volume":"24","author":"H Tattan-Birch","year":"2022","unstructured":"Tattan-Birch H, Jackson SE, Dockrell M, Brown J (2022) Tobacco-free nicotine pouch use in Great Britain: a representative population survey 2020-2021. Nicotine Tob Res 24(9):1509\u20131512. https:\/\/doi.org\/10.1093\/ntr\/ntac099","journal-title":"Nicotine Tob Res"},{"issue":"25","key":"4278_CR117","doi-asserted-by":"publisher","first-page":"00296","DOI":"10.1016\/S2468-2667(25)00296-8","volume":"S2468\u20132667","author":"H Tattan-Birch","year":"2025","unstructured":"Tattan-Birch H, Jackson SE, Shahab L, Buss V, Sun T, Read D, Taylor E, Brown J (2025) Oral nicotine pouch use in Great Britain: a repeat cross-sectional study, 2020\u201325. Lancet Public Health S2468\u20132667(25):00296\u201300298. https:\/\/doi.org\/10.1016\/S2468-2667(25)00296-8","journal-title":"Lancet Public Health"},{"key":"4278_CR118","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntae295","author":"L Brose","year":"2025","unstructured":"Brose L, Bunce L, Cheeseman H (2025) Prevalence of nicotine pouch use among youth and adults in Great Britain-analysis of cross-sectional, nationally representative surveys. Nicotine Tob Res. https:\/\/doi.org\/10.1093\/ntr\/ntae295","journal-title":"Nicotine Tob Res"},{"key":"4278_CR119","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7335a3","author":"E Park-Lee","year":"2024","unstructured":"Park-Lee E, Jamal A, Cowan H, Sawdey MD, Cooper MR, Birdsey J, West A, Cullen KA (2024) Notes from the field: E-cigarette and nicotine pouch use among middle and high school students - United States, 2024. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm7335a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4278_CR120","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18332\/tpc\/163243","volume":"7;9","author":"S Tosakoon","year":"2023","unstructured":"Tosakoon S, Romm KF, Berg CJ (2023) Nicotine pouch awareness, use and perceptions among young adults from six metropolitan statistical areas in the United States. Tob Prev Cessat 7;9:19. https:\/\/doi.org\/10.18332\/tpc\/163243","journal-title":"Tob Prev Cessat"},{"key":"4278_CR121","doi-asserted-by":"publisher","first-page":"102239","DOI":"10.1016\/j.pmedr.2023.102239","volume":"34","author":"M Patel","year":"2023","unstructured":"Patel M, Kierstead EC, Kreslake J, Schillo BA (2023) Patterns of oral nicotine pouch use among U.S. adolescents and young adults. Prev Med Rep 34:102239. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102239","journal-title":"Prev Med Rep"},{"key":"4278_CR122","unstructured":"CDC Foundation. Monitoring Tobacco Product Use Among Youth and Young Adults in the U.S. TEEN+ Data Brief, Issue 2. 2025. Available from: https:\/\/tobaccomonitoring.org\/wp-content\/uploads\/2025\/09\/Tobacco-Epidemic-Evaluation-Network-Data-Brief-Issue-2.pdf."},{"key":"4278_CR123","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ijc.21841","volume":"15;119","author":"A Roosaar","year":"2006","unstructured":"Roosaar A, Johansson AL, Sandborgh-Englund G, Nyr\u00e9n O, Ax\u00e9ll T (2006) A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int J Cancer 15;119:392\u2013397. https:\/\/doi.org\/10.1002\/ijc.21841","journal-title":"Int J Cancer"},{"key":"4278_CR124","doi-asserted-by":"publisher","unstructured":"German Federal Institute for Risk Assessment (BfR). Health risk assessment of nicotine pouches. Updated BfR Opinion no. 023\/2022, 7 October 2022. https:\/\/doi.org\/10.17590\/20220204-105615. Available from: https:\/\/www.bfr.bund.de\/cm\/349\/health-risk-assessment-of-nicotine-pouches.pdf","DOI":"10.17590\/20220204-105615"},{"issue":"9","key":"4278_CR125","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s00204-023-03538-9","volume":"97","author":"N Mallock-Ohnesorg","year":"2023","unstructured":"Mallock-Ohnesorg N, Rinaldi S, Malke S, Dreiack N, Pieper E, Laux P, Schulz T, Zimmermann R, Luch A (2023) Oral nicotine pouches with an aftertaste? Part 1: screening and initial toxicological assessment of flavorings and other ingredients. Arch Toxicol 97(9):2357\u20132369. https:\/\/doi.org\/10.1007\/s00204-023-03538-9","journal-title":"Arch Toxicol"},{"key":"4278_CR126","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ntr\/ntae111","volume":"24;27","author":"JT Kent","year":"2025","unstructured":"Kent JT, Mok G, Austin E (2025) Nicotine toxicity from repeat use of nicotine pouches. Nicotine Tob Res 24;27:767\u2013768. https:\/\/doi.org\/10.1093\/ntr\/ntae111","journal-title":"Nicotine Tob Res"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04278-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:28:37Z","timestamp":1777958917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04278-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4278"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04278-1","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KF is an external research associate at the University of West Attica and the University of Patras in Greece. He has published more than 110 studies on smoking and tobacco harm reduction. He has no conflict of interest to report for e-cigarettes and heated tobacco products. Very recently, he has contributed to the development of research protocols for nicotine pouches\u00a0for a manufacturer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethics committee approval was sought for this study since it does not involve human subjects or experimental procedures on animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}